AI Healthcare Startup Abridge Raises $300M in Series E Funding Led by Andreessen Horowitz

Abridge, a startup specializing in AI note-taking tools for physicians, has secured $300 million in its latest Series E funding round. The investment, which values the company at $5.3 billion, was spearheaded by Andreessen Horowitz, with participation from Khosla Ventures.

Abridge's CEO, Dr. Shiv Rao, highlighted the growing acceptance of AI-centered solutions in healthcare, particularly in the area of generative AI. The company's technology utilizes ambient-listening technology to transcribe doctor-patient conversations, effectively reducing the time spent by physicians on administrative tasks. .

Read more about the funding here.